Literature DB >> 20848442

Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.

Marcia P Maahs1, Alan A Azambuja, Maria M Campos, Fernanda G Salum, Karen Cherubini.   

Abstract

BACKGROUND: This work aimed at determining whether bisphosphonate therapy produces a sufficient condition for jaw osteonecrosis after tooth extraction.
METHODS: Rats were allocated into 3 groups: (1) 11 rats treated with alendronate, (2) 10 rats treated with zoledronic acid, and (3) 10 control rats. The animals were subjected to tooth extractions, and at the end of bisphosphonate therapy, they were humanely killed. Histologic sections of the surgical site were processed and analyzed.
RESULTS: The zoledronic acid group showed higher incidences of osteonecrosis, inflammatory infiltrate, and microorganisms. There was no significant difference for epithelial or connective tissue, root fragments, vital bone, and positive staining for vascular endothelial growth factor (VEGF) among the groups.
CONCLUSION: Zoledronic acid is associated with jaw osteonecrosis, whereas alendronate did not produce a condition sufficient for osteonecrosis after tooth extraction. Neither zoledronic acid nor alendronate was associated with a reduced immunohistochemical expression of VEGF in vital bone at the tooth extraction site.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20848442     DOI: 10.1002/hed.21422

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  18 in total

Review 1.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

2.  Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw.

Authors:  Mohammad Zandi; Arash Dehghan; Payam Amini; Shideh Doulati; Leila Rezaeian
Journal:  Clin Oral Investig       Date:  2019-02-04       Impact factor: 3.573

3.  Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Authors:  J Ignacio Aguirre; Mohammed P Akhter; Donald B Kimmel; Jennifer E Pingel; Alyssa Williams; Marda Jorgensen; Lakshmyya Kesavalu; Thomas J Wronski
Journal:  J Bone Miner Res       Date:  2012-10       Impact factor: 6.741

4.  Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.

Authors:  Valesca S Koth; Maria A Figueiredo; Fernanda G Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2017-02-17       Impact factor: 2.419

5.  Imaging and histomorphometric evaluation of mandible and tibia of rats treated with bisphosphonates.

Authors:  Stephanie Joana Roman Martelli; Melissa Feres Damian; André Ribeiro Schinestsck; Lauren Frenzel Schuch; Andreia Morales Cascaes; Ana Carolina Uchoa Vasconcelos
Journal:  Oral Maxillofac Surg       Date:  2019-11-04

6.  Ozonated oil effect for prevention of medication-related osteonecrosis of the jaw (MRONJ) in rats undergoing zoledronic acid therapy.

Authors:  C G J Monteiro; E M Vieira; C Emerick; R S Azevedo; V A B Pascoal; N Homsi; R X Lins
Journal:  Clin Oral Investig       Date:  2021-04-25       Impact factor: 3.573

7.  A novel model of bisphosphonate-related osteonecrosis of the jaw in rats.

Authors:  Huawei Yang; Hui Pan; Fang Yu; Kai Chen; Guangwei Shang; Yuanzhi Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

8.  Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy-histomorphometric and immunohistochemical analysis.

Authors:  Miguel Luciano Silva; Leandro Tasso; Alan Arrieira Azambuja; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Vinicius Duval da Silva; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

9.  Morphological and immunohistochemical features of tooth extraction sites in rats treated with alendronate, raloxifene, or strontium ranelate.

Authors:  Valesca Sander Koth; Fernanda Gonçalves Salum; Maria Antonia Zancanaro de Figueiredo; Karen Cherubini
Journal:  Clin Oral Investig       Date:  2020-09-23       Impact factor: 3.573

10.  Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling.

Authors:  Vanessa Costa de Sousa Ferreira; Amanda Pimentel Lopes; Nicholas Militão Alves; Fatima Regina Nunes Sousa; Karuza Maria Alves Pereira; Delane Viana Gondim; Vírginia Claúdia Carneiro Girão; Renata Ferreira Carvalho Leitão; Paula Goes
Journal:  Clin Oral Investig       Date:  2020-09-08       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.